http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200827718-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a01717442a2a920617ac88dbdf9caacc |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2007-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d3eebc3355d9ef7b6d337f72950bee7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f769c6767cb5fc44e454c6549ff8ebe6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a76839275ec605cb5db5d092468fd038 |
publicationDate | 2008-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-200827718-A |
titleOfInvention | Alpha-enolase specific antibody and method of use |
abstract | This invention relates to a method of monitoring cancer development by determining the abundance of alpha-enolase protein wherein increased abundance is an indication of the severity of cancer. In another embodiment, the invention relates to a method of detecting cancer malignancy by determining the abundance of alpha-enolase antibodies in a sample wherein low levels of such antibodies indicates the malignancy of cancer. Also provided is a method of suppressing tumor growth by inducing the anti-ENO1 immune response. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112451661-A |
priorityDate | 2006-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1242.